Central Nervous System Toxicity During the Induction of General Anesthesia After Intravenous Bolus of Lidocaine

Review Article | DOI: https://doi.org/10.31579/JCRA/003Copy

Central Nervous System Toxicity During the Induction of General Anesthesia After Intravenous Bolus of Lidocaine

  • Melanie M. Stipp 1
  • Jingping Wang 1*
  • 1 Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

*Corresponding Author: ingping Wang, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, USA. E

Citation: Melanie MS and Jingping W., (2019) Central Nervous System Toxicity during the Induction of General Anesthesia After Intravenous Bolus of Lidocaine. International Journal of Mediators of Inflammation, 2(1); DOI: 10.31579/JCRA/003

Copyright: ©2019. Jingping W. This is an open-access article distributed under the termsof the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 11 November 2019 | Accepted: 12 December 2019 | Published: 19 December 2019

Keywords: lidocaine; central nervous system (cns); cardiovascular toxicity

Abstract

Lidocaine is a frequently utilized intravenous adjuvant for the induction of general anesthesia. Despite its wide therapeutic margin of safety, central nervous system (CNS) and cardiovascular toxicity may ensue. A healthy, 22-year-old female presented for a temporomandibular joint (TMJ) arthroscopy and manipulation. After a 2 mg kg-1 intravenous bolus of lidocaine, the patient developed symptoms of lidocaine CNS toxicity. This paper will overview the pharmacology, structure and mechanism of lidocaine, the recognition and management of systemic lidocaine toxicity, and the patient specific contributors to the development of lidocaine toxicity. Subsequently, innovative practice recommendations will be discussed. 

Objectives

  1. Summarize a description of the case including: the patient’s profile, the patient’s medications, the anesthesia management, the clinical presentation of lidocaine toxicity, and the management of lidocaine toxicity.
  2. Summarize the pharmacology, structure and mechanism of lidocaine.
  3. Understand the mechanism, recognition, and management of systemic lidocaine toxicity.
  4. Discuss the potential contributors to the development of lidocaine toxicity.
  5. Discuss novel practice recommendations.

Introduction

Lidocaine is a frequently utilized intravenous adjuvant for the induction of general anesthesia. 15 Despite its wide therapeutic margin of safety, central nervous system (CNS) and cardiovascular toxicity may ensue. 23 Vigilance is essential in the recognition and immediate treatment of suspected systemic lidocaine toxicity. We present a case of CNS toxicity after an intravenous bolus of lidocaine during the induction of general anesthesia.

Case Presentation

A 22-year-old female presented for a temporomandibular joint (TMJ) arthroscopy and manipulation. The patient’s pertinent medical history included orofacial pain and daily migraines refractory to other treatment modalities including thoracenteses, physical therapy and use of a night guard. The patient had a past medical history significant for Chiari 1 malformation, intractable migraines with aura, tethered spinal cord, seasonal allergies, mild asthma, gastroesophageal reflux, MVA, and post-operative nausea and vomiting.  

The patient’s home medication list included: acetaminophen 325 mg tablet, albuterol 90 mcg/actuation inhaler, almotriptan 12.5 MG tablet, aspirin-acetaminophen-caffeine 250-250-65 mg per tablet, botulinum toxin type A 100 unit SolR, cetirizine 10 MG tablet, fluticasone propionate 50 mcg/actuation nasal spray, ibuprofen 200 MG tablet, levonorgestrel 14 mcg/24 hour, melatonin 10 mg tablet, oxycodone 5 MG tablet, and tramadol 50 mg tablet.  Prior to the induction of anesthesia, the patient received 20 mg of intravenous famotidine, a transdermal 1.5 mg scopolamine patch, and an oral 975 mg dosage of acetaminophen. 

During induction of anesthesia, the patient developed anxiety, tinnitus, a foul taste in the mouth, and tremors immediately after receiving a dose of lidocaine at a 2 mg kg-1.  Patient was then given 2 mg morphine and 150 mg propofol followed by a prophylactic 2 mg intravenous bolus of midazolam. Subsequently, the patient received 80 mg of succinylcholine for intubation. A 6.0 mm Nasal Rae tube was successfully placed and confirmed via fiberoptic bronchoscopy. The patient was administered an FiO2 of 100%, inhaled volatile anesthetic (sevoflurane) and hyperventilated to an ETCO2 of 30 mmHg.  The notable hemodynamic changes after intubation were tachycardia (HR=167 BPM) and hypertension (BP=150/85; MAP=106mmHg), which were corrected with a 10 mg bolus of IV esmolol. The patient’s ventilation was maintained with a target ETCO2 of 30-32 mmHg throughout the case.  

The patient’s cardiovascular status remained stable throughout the duration of the procedure. The patient received no further administration of lidocaine by the surgical or anesthesia team. There were no post-operative complications.

Lidocaine: Pharmacology and Clinical Indications

Lidocaine is a frequently utilized intravenous adjuvant for the induction of general anesthesia. 15 Lidocaine’s molecular structure consists of a hydrophilic diethylglycine molecule bound via an amide bond to a hydrophobic aromatic benzene ring. 6 The amphipathic nature of lidocaine permits permeability across both hydrophobic and hydrophilic membranes. 22 Lidocaine metabolism is hepatic, via cytochrome P450 3A4. 5 Lidocaine elimination half-life is 1.5- 2 hour with renal excretion. 3, 6

The molecular structure of lidocaine (2-diethylaminoaceto-2’,6’-xylidide) 17 is displayed below:

figure

Sodium channel antagonists, such as lidocaine, inhibit ectopic discharges of TTX-sensitive and TTX-resistant sodium channels without affecting nerve conduction. 15 Sodium channel blockade results in a reduction of neuronal action potential initiation, propagation and facilitates membrane stabilization. 26 The peak plasma concentrations (Cmax) obtained from a 1.5-2 mg/kg bolus of intravenous lidocaine inhibit a small number of sodium channels, thus secondary and tertiary mechanisms are likely involved.  In progressively higher serum concentrations, lidocaine will inhibit voltage-gated potassium channels, voltage-gated calcium channels and nicotinic acetylcholine (nAch) receptors. 22

Intravenous lidocaine has been shown to target polymorphonuclear granulocytes by interfering with upstream G-protein pro-inflammatory signaling and the release of reactive oxygen species and cytokines. 7 Intravenous lidocaine results in a reduction of cerebral metabolic rate, cerebral blood flow, and cerebral metabolic oxygen consumption, thus, reducing energy required for neuronal membrane stabilization. 1,15 The CNS inhibitory effects of systemic lidocaine may be influenced by lidocaine mediated strychnine-sensitive glycine receptors of wide dynamic range neurons in the spinal cord. 4 Lidocaine is also shown to block the K+-Cl− cotransporter (KCC) on γ-aminobutyric acid (GABAA) receptors. 16 This blockade and lidocaine mediated inhibition likely plays a role in the progressive nervous system symptoms and seizure activity observed in systemic lidocaine CNS toxicity. 29

N-methyl-D-aspartate (NMDA) receptors play an important role in nociception via fast excitatory neurotransmission in the CNS 24. Lidocaine plays a role in reducing hyperalgesia by its effects on NR1/2A NMDA receptor subunits.11 Lidocaine is shown to indirectly inhibit NMDA via its effects on protein kinase C (PKC) in a concentration dependent manner. 11 Lidocaine inhibits PKC mediated functions intracellularly, resulting in a reduction of PKC phosphorylation of NMDA subunits, consequently, reducing downstream signaling and NMDA receptor function. 11

A 1.5 mg kg-1 bolus of intravenous lidocaine during anesthetic induction serves a number of purposes: the attenuation of pain response to propofol and/or etomidate administration, blunting the cough reflex elicited by a rapid fentanyl bolus and airway instrumentation, reduction of succinylcholine-induced elevations in intragastric pressure and ICP, mitigating the hemodynamic response (hypertension and tachycardia) from laryngoscopy, blunting increases in ICP secondary to airway instrumentation, and to mitigate airway reactivity. 8, 13, 14, 15, 18, 27, 30 Systemic lidocaine has also been utilized for its analgesic, anti-inflammatory properties, and its synergistic reduction in the minimum alveolar concentration (MAC) of volatile anesthetics by 10-28%. 9, 27

Table

 

Pharmacokinetics

The plasma concentration of lidocaine is dependent upon several factors including: dosage, absorption, distribution, elimination, patient age, patient hepatic function, patient cardiovascular status, and plasma protein binding. 3 Lidocaine injection can be illustrated by a two-compartment model resulting in an initial rapid reduction of peak plasma concentrations (Cmax). 3, 23  The primary α-phase includes rapid uptake to the lungs and distribution to the highly vascular compartment. 3, 23 The subsequent β-phase results in a slow re-distribution to vascular poor regions. 3, 23 The vasodilatory effects of lidocaine contribute to its short duration of action and enhanced systemic absorption. 23

Lidocaine’s high hepatic extraction ratio (0.63) makes it dependent on hepatic blood flow. 21 The metabolism of lidocaine is dependent upon CYP450 34A enzyme function and hepatocellular perfusion. 3 The hepatic metabolism of lidocaine occurs via CYP450 34A enzyme N-dealkylation and hydroxylation. 3 The CYP450 34A metabolism results in the formation of monoethylglycinexylidide via hepatic oxidative dealkylation and subsequently the formation of glycine xylidine via hydroxylation. 3,23 The elimination half-life (t 1/2/β) of lidocaine is 1.5-2 hours and excretion of metabolites occurs via the kidney with <5% excreted unmetabolized3.

Factors that may influence the unbound free fraction of systemic lidocaine include: a reduction in plasma protein binding, increased total interstitial volume, and reduced total plasma volume. 21 The unbound free fraction of systemic lidocaine is responsible for its therapeutic effects. 5 Increases in unbound free fraction of lidocaine may be a result of physiological states such as: pregnancy, cirrhosis, and newborn age. 3

Central Nervous System Toxicity

Systemic lidocaine toxicity is a life-threatening emergency that begins with CNS symptoms, and if left untreated, may progress to cardiovascular toxicity and fatality.  Lidocaine toxicity is dose dependent and largely influenced by Cmax. 3 Cmax is directly influenced by the free fraction of lidocaine available. 5 The free fraction of lidocaine is contingent upon plasma protein binding, total interstitial volume, and plasma volume. 21 The extent of plasma protein binding is influenced by the serum pH and patient levels of alpha 1-glycoprotein and albumin. 3 There is an indirect relationship between seizure threshold and the levels of serotonin (5-hydroxytryptophan) in the central nervous system. 23 Thus, medications that elevated levels of 5-hydroxytryptophan may increase the risk for lidocaine CNS toxicity. 23

At a Cmax of 3-4 mcg mL-1 patients develop circumoral numbness, restlessness, tinnitus, tingling of the face, metallic taste in the mouth, auditory hallucinations, and visual hallucinations. 3, 20, 22 At a Cmax of 5-10 mcg mL-1 tremors and seizure activity may ensue. 3, 20, 22 Thus, intravenous lidocaine boluses should be titrated to a serum concentration less than 5-10 mcg mL-1, the seizure threshold for lidocaine. 15, 22 If toxicity remains untreated, it may progress to bradycardia, arrhythmia, hypotension, cardiac and respiratory arrest. 22

Management of Central Nervous System Toxicity

The initial management of lidocaine toxicity includes the following steps: call for back-up clinical support, stop lidocaine administration, intubation to secure the airway and administer a benzodiazepine. 22 In a patient with no cardiovascular symptoms, propofol can also be administered at a 1 mg kg-1 IV. 22 A 20% lipid emulsion may be administered at a 1.5 mL kg-1 followed by a continuous infusion of 0.25-0.5 mL kg-1 min-1. 22 If the toxicity progresses to cardiovascular compromise, ACLS should be followed with the following modifications: use 10-100 mcg doses of epinephrine, utilize amiodarone for ventricular arrhythmias, avoid vasopressin, calcium channel blockers, beta-blockers, and consider cardiopulmonary bypass for patients that do not respond to treatment. 22

Discussion

The possible explanations for CNS toxicity in this case include: pharmaceutical interactions, cytochrome P450 3A4 mediated drug-drug interactions, concurrent beta-blockade, rate of administration and dosage.

  1. Pharmaceutical Interactions: The patient’s home medications included tramadol and amlotriptan. Tramadol is a known noradrenaline and serotonin reuptake re-uptake inhibitor. 23 Almotriptan is a serotonin agonist Tramadol and almotriptan enhance serotonergic transmission in the CNS, reducing the seizure threshold, consequently, increasing the risk for lidocaine-induced CNS toxicity. 23 Increased serotonergic transmission in the CNS results in a reduction of the seizure threshold consequently increasing the risk for lidocaine related CNS toxicity 23.
  2. Cytochrome P450 3A4 Mediated Drug-Drug interactions:  The patient’s home medication list includes the following competing substrates for CYP 450 3A4: oxycodone, cetirizine, and levonorgestrel. Moreover, benzodiazepines acts as a competing substrate. 12, 5, 23 Simultaneous CYP450 3A4 metabolism increases Cmax. 5, 12, 23 Medications that are simultaneously metabolized by CYP 450 3A4 are shown to increase risk of toxicity in patients administered lidocaine. 1, 5, 8 This results an increase in Cmax. 5, 12, 23 Likewise, simultaneous administration with known CYP450 3A4 inhibitors will result in an increase in Cmax.
  3. Concurrent Beta-Blockade: Concurrent beta-blockade may also contribute to lidocaine CNS toxicity. Sympathetic suppression by small dose esmolol reduces blood flow to splanchic organs 25. The concomitant reduction of HR and decrease in hepatic blood flow and renal clearance, may result in an increased Cmax 25.
  4. Bolus Dosing: A small study (n=8), showed that the administration a 1 mg kg-1 bolus dosing of intravenous lidocaine produces mild symptoms of CNS toxicity for 5 +/- 1.4 minutes duration including: circumoral numbness, metallic taste, dizziness, hallucinations, and slurred speech. 10 It was identified, however, that the rapidity of exposure of lidocaine to the CNS had the greatest influence on the precipitation of CNS toxicity symptoms. 10 The plasma concentration threshold where CNS toxicity occurs is more likely due to the rate of increase of the serum concentration than due to the total amount of drug injected. 23
  5. Rate of Administration: The rate of lidocaine administration influences Cmax. A 2 mg kg-1 bolus of intravenous lidocaine theoretically results in a Cmax of 6.6-8.5 mcg/mL. 15 The rate increase of Cmax likely has more influence on lidocaine toxicity than dosing. 23 Rapid bolus administration of 2% lidocaine into the epidural space, has been shown to significantly (P<0.0005) increase Cmax when compared to a 20 mg min-1 infusion. 28 There are no studies in the literature that review the effect on Cmax after intravenous bolus administration. 
  6. Genetic Polymorphism: In the absence of a normal therapeutic response, genetic polymorphism should be considered. There are 46 known single nucleotide polymorphisms of CYP450 3A4 affecting drug metabolism. 19 Moreover, CYP450 3A4 enzyme phenotypic expression varies 30-fold between individuals. 12

Practice Recommendations

  1. Caution with the co-administration of lidocaine with: SSRIs, SNRIs, serotonin agonists, antihistamines, beta-blockers, calcium channel blockers, macrolide antibiotics, antifungals, and benzodiazepines. 12, 23
  2. Caution with concurrent administration of intravenous lidocaine with known CYP 450 3A4 inhibitors and medications metabolized by CYP 450 3A4. 5, 12, 23
  3. Consider dose reduction for intravenous lidocaine bolus administration.
  4. Avoid the rapid bolus of intravenous lidocaine.
  5. Genetic polymorphism should be considered when an abnormal therapeutic response is appreciated at standard doses. 12, 19

Notes

The authors declare that no competing interests exist. 

Ethical Declarations

Informed consent was obtained from the patient in this case study.  All associated patient identifiers were removed for the purposes of this paper.   

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad